Abstract
Long noncoding RNAs (lncRNAs) have been reported to be implicated in various biological and pathological processes. However, the function and mechanism of XIST in vascular smooth muscle cells (VSMCs) remains unknown. The levels of XIST, miR-599, and TLR4 were tested by RT-qPCR. VSMCs and human mononuclear cells (U937) treated with ox-LDL were used as atherosclerosis (AS) cell models. The CCK-8 assay was adopted to detect cell viability. Cell apoptosis was examined by the TUNEL assay. A dual-luciferase reporter assay was employed to investigate the interaction between miR-599 and XIST or TLR4. In this research, we uncovered that the XIST level was elevated in the serum of AS patients and ox-LDL-treated AS cell models. Functional analysis revealed that XIST depletion restrained cell proliferation, while induced the apoptosis in AS cell models. Besides, miR-599 was verified to be a direct downstream target of XIST and miR-599 inhibitor reversed the effects of XIST knockdown on AS progression. Finally, we demonstrated that XIST increased TLR4 expression by serving as a ceRNA of miR-599. All these findings manifested the role of the XIST/miR-599/TLR4 axis in AS development.
Similar content being viewed by others
Data Availability
The analyzed data sets generated during the present study are available from the corresponding author on reasonable request.
References
Zhong, X., X. Ma, L. Zhang, Y. Li, Y. Li, and R. He. 2018. MIAT promotes proliferation and hinders apoptosis by modulating miR-181b/STAT3 axis in ox-LDL-induced atherosclerosis cell models. Biomedicine & Pharmacotherapy 97: 1078–1085.
Zhu, H., T. Zhao, and J. Liu. 2018. Role of paraoxonase 1 activity and oxidative/antioxidative stress markers in patients with acute cerebral infarction. Clinical Laboratory 64 (6): 1049–1053.
Dinh, Q.N., S. Chrissobolis, H. Diep, C.T. Chan, D. Ferens, G.R. Drummond, and C.G. Sobey. 2017. Advanced atherosclerosis is associated with inflammation, vascular dysfunction and oxidative stress, but not hypertension. Pharmacological Research 116: 70–76.
Tofield, A. 2017. ESC CardioMed: The new ESC textbook of cardiovascular medicine, an innovative digital textbook database for today’s cardiologists from the European Society of Cardiology will soon be available. European Heart Journal 38 (44): 3252–3253.
Yang, L., J.E. Froberg, and J.T. Lee. 2014. Long noncoding RNAs: Fresh perspectives into the RNA world. Trends in Biochemical Sciences 39 (1): 35–43.
Yao, X., C. Yan, L. Zhang, Y. Li, and Q. Wan. 2018. LncRNA ENST00113 promotes proliferation, survival, and migration by activating PI3K/Akt/mTOR signaling pathway in atherosclerosis. Medicine (Baltimore) 97 (16): e0473.
Cui, C., X. Wang, X.M. Shang, L. Li, Y. Ma, G.Y. Zhao, Y.X. Song, X.B. Geng, B.Q. Zhao, M.R. Tian, and H.L. Wang. 2019. lncRNA 430945 promotes the proliferation and migration of vascular smooth muscle cells via the ROR2/RhoA signaling pathway in atherosclerosis. Molecular Medicine Reports 19 (6): 4663–4672.
Zhu, H., T. Zheng, J. Yu, L. Zhou, and L. Wang. 2018. LncRNA XIST accelerates cervical cancer progression via upregulating Fus through competitively binding with miR-200a. Biomedicine & Pharmacotherapy 105: 789–797.
Zhang, Y., Y. Zhu, G. Gao, and Z. Zhou. 2019. Knockdown XIST alleviates LPS-induced WI-38 cell apoptosis and inflammation injury via targeting miR-370-3p/TLR4 in acute pneumonia. Cell Biochemistry and Function 37 (5): 348–358.
Hu, W.N., Z.Y. Duan, Q. Wang, and D.H. Zhou. 2019. The suppression of ox-LDL-induced inflammatory response and apoptosis of HUVEC by lncRNA XIAT knockdown via regulating miR-30c-5p/PTEN axis. European Review for Medical and Pharmacological Sciences 23 (17): 7628–7638.
Bartel, D.P. 2009. MicroRNAs: Target recognition and regulatory functions. Cell 136 (2): 215–233.
Maziere, P., and A.J. Enright. 2007. Prediction of microRNA targets. Drug Discovery Today 12 (11–12): 452–458.
Fang, M., Y. Li, Y. Wu, Z. Ning, X. Wang, and X. Li. 2019. miR-185 silencing promotes the progression of atherosclerosis via targeting stromal interaction molecule 1. Cell Cycle 18 (6–7): 682–695.
Su, G., G. Sun, H. Liu, L. Shu, and Z. Liang. 2018. Downregulation of miR-34a promotes endothelial cell growth and suppresses apoptosis in atherosclerosis by regulating Bcl-2. Heart and Vessels 33 (10): 1185–1194.
Qu, Y., and N. Zhang. 2018. miR-365b-3p inhibits the cell proliferation and migration of human coronary artery smooth muscle cells by directly targeting ADAMTS1 in coronary atherosclerosis. Experimental and Therapeutic Medicine 16 (5): 4239–4245.
Xie, B., et al. 2015. miR-599 inhibits vascular smooth muscle cells proliferation and migration by targeting TGFB2. PLoS One 10 (11): e0141512.
Li, F.P., D.Q. Lin, and L.Y. Gao. 2018. LncRNA TUG1 promotes proliferation of vascular smooth muscle cell and atherosclerosis through regulating miRNA-21/PTEN axis. European Review for Medical and Pharmacological Sciences 22 (21): 7439–7447.
Tao, K., Z. Hu, Y. Zhang, D. Jiang, and H. Cheng. 2019. LncRNA CASC11 improves atherosclerosis by downregulating IL-9 and regulating vascular smooth muscle cell apoptosis and proliferation. Bioscience, Biotechnology, and Biochemistry 83 (7): 1284–1288.
Zhou, K., J. Yang, X. Li, and W. Chen. 2019. Long non-coding RNA XIST promotes cell proliferation and migration through targeting miR-133a in bladder cancer. Experimental and Therapeutic Medicine 18 (5): 3475–3483.
Chen, X., D. Xiong, L. Ye, K. Wang, L. Huang, S. Mei, J. Wu, S. Chen, X. Lai, L. Zheng, and M. Wang. 2019. Up-regulated lncRNA XIST contributes to progression of cervical cancer via regulating miR-140-5p and ORC1. Cancer Cell International 19: 45.
Sun, J., and Y. Zhang. 2019. LncRNA XIST enhanced TGF-beta2 expression by targeting miR-141-3p to promote pancreatic cancer cells invasion. Bioscience Reports: 39(7).
Pirillo, A., G.D. Norata, and A.L. Catapano. 2013. LOX-1, OxLDL, and atherosclerosis. Mediators of Inflammation 2013: 152786.
Zhang, L., H. Cheng, Y. Yue, S. Li, D. Zhang, and R. He. 2018. H19 knockdown suppresses proliferation and induces apoptosis by regulating miR-148b/WNT/beta-catenin in ox-LDL-stimulated vascular smooth muscle cells. Journal of Biomedical Science 25 (1): 11.
Zhang, L., H. Cheng, Y. Yue, S. Li, D. Zhang, and R. He. 2018. TUG1 knockdown ameliorates atherosclerosis via up-regulating the expression of miR-133a target gene FGF1. Cardiovascular Pathology 33: 6–15.
Li, C., Y. Tian, Y. Liang, and Q. Li. 2020. Circ_0008035 contributes to cell proliferation and inhibits apoptosis and ferroptosis in gastric cancer via miR-599/EIF4A1 axis. Cancer Cell International 20: 84.
Jiang, Y., X. Wang, J. Zhang, and R. Lai. 2018. MicroRNA-599 suppresses glioma progression by targeting RAB27B. Oncology Letters 16 (1): 1243–1252.
Wang, J., A. du, H. Wang, and Y. Li. 2020. MiR-599 regulates LPS-mediated apoptosis and inflammatory responses through the JAK2/STAT3 signalling pathway via targeting ROCK1 in human umbilical vein endothelial cells. Clinical and Experimental Pharmacology & Physiology 47 (8): 1420–1428.
Du, X.J., and J.M. Lu. 2018. MiR-135a represses oxidative stress and vascular inflammatory events via targeting toll-like receptor 4 in atherogenesis. Journal of Cellular Biochemistry 119 (7): 6154–6161.
Yang, K., Y.S. He, X.Q. Wang, L. Lu, Q.J. Chen, J. Liu, Z. Sun, and W.F. Shen. 2011. MiR-146a inhibits oxidized low-density lipoprotein-induced lipid accumulation and inflammatory response via targeting toll-like receptor 4. FEBS Letters 585 (6): 854–860.
Acknowledgments
We are grateful to all the participants in this work.
Author information
Authors and Affiliations
Contributions
KY as the first author contributed significantly to analysis and manuscript preparation. XG as the corresponding author contributed to the conception of the study. KY, YX, and XG helped perform the analyses with constructive discussions. All authors read and approved the manuscript and agree to be accountable for all aspects of the research in ensuring that the accuracy or integrity of any part of the work is appropriately investigated and resolved.
Corresponding author
Ethics declarations
Competing Interests
The authors declare that they have no competing interests.
Ethics Approval and Consent to Participate
The study protocol was approved by the Affiliated Changzhou No.2 People’s Hospital of Nanjing Medical University, and all patients provided written informed consent. All of the procedures were in compliance with The Declaration of Helsinki and relevant policies in China.
Patient Consent for Publication
Not applicable.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Yang, K., Xue, Y. & Gao, X. LncRNA XIST Promotes Atherosclerosis by Regulating miR-599/TLR4 Axis. Inflammation 44, 965–973 (2021). https://doi.org/10.1007/s10753-020-01391-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10753-020-01391-x